Novel SCN5A mutation (Q55X) associated with age-dependent expression of Brugada syndrome presenting as neurally mediated syncope

Heart Rhythm

Volumn 4, Issue 4, 2007, Pages 516-519

  Makita, Naomasa ^a   Sumitomo, Naokata ^b   Watanabe, Ichiro ^b   Tsutsui, Hiroyuki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Brugada syndrome; Neurally mediated syncope; SCN5A; Tilt test

Indexed keywords

CILOSTAZOL; PILSICAINIDE; SODIUM CHANNEL; SODIUM CHANNEL SCN5A; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; BRUGADA SYNDROME; CASE REPORT; CODON; ELECTROCARDIOGRAM; EMOTIONAL STRESS; EXON; GENE EXPRESSION; GENE MUTATION; GENETIC SCREENING; HEAD TILTING; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE CONDUCTION; HEART VENTRICLE FIBRILLATION; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; MALE; PRIORITY JOURNAL; PROVOCATION TEST; SINOATRIAL CONDUCTION; SINUS ARREST; ST SEGMENT ELEVATION; STANDING; SYNCOPE; VEIN PUNCTURE;

ACTION POTENTIALS; ADOLESCENT; AGE FACTORS; ATRIOVENTRICULAR NODE; BRUGADA SYNDROME; CODON, NONSENSE; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; EXONS; HUMANS; MALE; MUSCLE PROTEINS; PEDIGREE; SINOATRIAL NODE; SODIUM CHANNELS; SYNCOPE, VASOVAGAL;

EID: 34247184614     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2006.10.028     Document Type: Article

References (18)

1. Antzelevitch C., Brugada P., Borggrefe M., Brugada J., Brugada R., Corrado D., Gussak I., LeMarec H., Nademanee K., Perez Riera A.R., Shimizu W., Schulze-Bahr E., Tan H., and Wilde A. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 111 (2005) 659-670
2. Yoshinaga M., Anan R., Nomura Y., Tanaka Y., Tanaka Y., Sarantuya J., Oku S., Nishi S., Kawano Y., Tei C., and Arima K. Prevalence and time of appearance of Brugada electrocardiographic pattern in young male adolescents from a three-year follow-up study. Am J Cardiol 94 (2004) 1186-1189
3. Marquez M.F., Rivera J., Hermosillo A.G., Iturralde P., Colin L., Moragrega J.L., and Cardenas M. Arrhythmic storm responsive to quinidine in a patient with Brugada syndrome and vasovagal syncope. Pacing Clin Electrophysiol 28 (2005) 870-873
4. Patruno N., Pontillo D., Anastasi R., Sunseri L., Giamundo L., and Ruggeri G. Brugada syndrome and neurally mediated susceptibility. Ital Heart J 6 (2005) 761-764
5. Samniah N., Iskos D., Sakaguchi S., Lurie K.G., and Benditt D.G. Syncope in pharmacologically unmasked Brugada syndrome: indication for an implantable defibrillator or an unresolved dilemma?. Europace 3 (2001) 159-163
6. Patruno N., and Pontillo D. Brugada syndrome and vasovagal syncope. Pacing Clin Electrophysiol 29 (2006) 215
7. Yokokawa M., Sato Y., Kitamura S., Tanaka K., Nagai T., Noda T., Satomi K., Suyama K., Kurita T., Aihara N., Kamakura S., and Shimizu W. Neurally-mediated syncope as a cause of syncope in patients with type 1 Brugada ECG. Heart Rhythm 3 (2006) S58
8. Atarashi H., Endoh Y., Saitoh H., Kishida H., and Hayakawa H. Chronotropic effects of cilostazol, a new antithrombotic agent, in patients with bradyarrhythmias. J Cardiovasc Pharmacol 31 (1998) 534-539
9. Tsuchiya T., Ashikaga K., Honda T., and Arita M. Prevention of ventricular fibrillation by cilostazol, an oral phosphodiesterase inhibitor, in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 13 (2002) 698-701
10. Sangwatanaroj S., Prechawat S., Sunsaneewitayakul B., Sitthisook S., Tosukhowong P., and Tungsanga K. New electrocardiographic leads and the procainamide test for the detection of the Brugada sign in sudden unexplained death syndrome survivors and their relatives. Eur Heart J 22 (2001) 2290-2296
11. Shimizu W., Matsuo K., Takagi M., Tanabe Y., Aiba T., Taguchi A., Suyama K., Kurita T., Aihara N., and Kamakura S. Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms. J Cardiovasc Electrophysiol 11 (2000) 396-404
12. Miyazaki T., Mitamura H., Miyoshi S., Soejima K., Aizawa Y., and Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Col Cardiol 27 (1996) 1061-1070
13. Wichter T., Matheja P., Eckardt L., Kies P., Schafers K., Schulze-Bahr E., Haverkamp W., Borggrefe M., Schober O., Breithardt G., and Schafers M. Cardiac autonomic dysfunction in Brugada syndrome. Circulation 105 (2002) 702-706
14. Schulze-Bahr E., Eckardt L., Breithardt G., Seidl K., Wichter T., Wolpert C., Borggrefe M., and Haverkamp W. Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease. Hum Mutat 21 (2003) 651-652
15. Beaufort-Krol G.C.M., van den Berg M.P., Wilde A.A.M., van Tintelen J.P., Viersma J.W., Bezzina C.R., and Bink-Boelkens M.T.E. Developmental aspects of long QT syndrome type 3 and Brugada syndrome on the basis of a single SCN5A mutation in childhood. J Am Coll Cardiol 46 (2005) 331-337
16. Matsuo K., Akahoshi M., Seto S., and Yano K. Disappearance of the Brugada-type electrocardiogram after surgical castration: a role for testosterone and an explanation for the male preponderance. Pacing Clin Electrophysiol 26 (2003) 1551-1553
17. Scornik F.S., Desai M., Brugada R., Guerchicoff A., Pollevick G.D., Antzelevitch C., and Perez G.J. Functional expression of "cardiac-type" Nav1.5 sodium channel in canine intracardiac ganglia. Heart Rhythm 3 (2006) 842-850
18. Makita N., Sasaki K., Groenewegen W.A., Yokota T., Yokoshiki H., Murakami T., and Tsutsui H. Congenital atrial standstill associated with coinheritance of a novel SCN5A mutation and connexin 40 polymorphisms. Heart Rhythm 2 (2005) 1128-1134